Cancer Therapeutics CRC (CTX)


Cancer Therapeutics (CTX) is an oncology focused small molecule drug discovery and early development biotechnology group, established under the Australian Government’s Cooperative Research Centre initiative in 2007. It is a unique collaborative partnership of leading research institutes, universities and commercial enterprises that translates Australia’s innovative research discoveries into new cancer drugs ready for clinical development.

CTX leverages the capabilities and expertise of its Industry Partners with those of a number of Australia’s pre-eminent medical research Institutes and universities and is always in search of licensing partners and investors that share its mission.

CTX also engages in ground breaking research targeted at the treatment of various cancers, has successfully out-licensed multiple oncology programs and has established itself as a leader in epigenetics and immuno-oncology.

For more information, visit the Cancer Therapeutics website here